EP Lab
This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.
There have been several safety reports to the FDA that COVID-19 patients receiving hydroxychloroquine and chloroquine, either alone or combined with azithromycin or other QT prolonging medicines, have caused serious These adverse events, including death. Events reported included QT interval prolongation, ventricular tachycardia and ventricular fibrillation.
Feature | Coronavirus (COVID-19) | April 24, 2020 | Dave Fornell, Editor
April 23, 2020 — The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors...
Feature | Coronavirus (COVID-19) | April 08, 2020
April 8, 2020 – The scientific community is learning more about the impact and interaction of cardiovascular diseases...
While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions
Feature | Coronavirus (COVID-19) | April 01, 2020 | Dave Fornell, Editor
April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart...
Sponsored Content
OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.
Feature | ECG | March 11, 2020
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness...
News | Atrial Fibrillation | March 29, 2020
March 29, 2020 — Patients with atrial fibrillation (AF) who took oral anticoagulants alone after undergoing...
Hydroxychloroquine causes prolonged QT intervals and cardiac arrhythmias, so this needs to be considered in patients being treated with this drug for COVID-19.
Feature | Coronavirus (COVID-19) | March 24, 2020 | Marianne Pop, Pharm.D, BCPS
It has been more than three months since the word coronavirus was uttered on everyone’s lips and all over the social...
Feature | Coronavirus (COVID-19) | March 20, 2020 | Dave Fornell, Editor
March 20, 2020 — The Centers for Medicare and Medicaid Services (CMS) announced March 18, 2020, that all elective...
Sponsored Content
Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.
Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
Videos | Coronavirus (COVID-19) | March 20, 2020
An interview with Ehtisham Mahmud, M.D., FSCAI, chief, Division of Cardiovascular Medicine, executive director of...
Philips Healthcare's new Fiber Optic RealShape (FORS) technology creates real-time 3-D imaging of anatomy and devices inside the body using light, rather than X-rays. FORS uses light traveling through hair-thin fiber optics inside special FORS enabled catheter and guidewires.
Feature | Angiography | March 12, 2020 | Dave Fornell, Editor
Philips is working on a prototype cath lab angiographic imaging system that might be able to replace the current X-ray...
OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.
Feature | ECG | March 11, 2020
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor
March 10, 2020 — Novel coronavirus (COVID-19) has claimed another large cardiology meeting, the European Heart Rhythm...
Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.
Feature | Cardiac Resynchronization Therapy Devices (CRT) | March 09, 2020 | Valentina Kutyifa M.D., Ph.D.
Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often...
News | EP Lab | March 05, 2020
March 5, 2020 — The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical SuperMap, an addition to its...
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
Coronavirus (COVID-19) and the FDA clearance of the Micra AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony, topped the news analytics in February 2020 on DAIC magazine. COVID-19 virus image courtesy of CDC.
Feature | March 02, 2020 | Dave Fornell, Editor
March 2, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
Videos | Structural Heart | February 27, 2020
Charles D. Resor, M.D., MSc, assistant director, cardiac catheterization lab, Tufts Medical Center and assistant...
Some of the new devices technologies to treat heart failure that are either in clinical trials or were recently cleared by the U.S. FDA.
Feature | Heart Failure | February 21, 2020 | Dave Fornell, Editor
There are several new tools being added to the clinical armamentarium in the fight against heart failure (HF). These...
